H1N1 reported in Gaza, Southern Sudan

NewsGuard 100/100 Score

Two women have become the first to die from H1N1 (swine flu) in Gaza, health officials said Monday, Agence France-Presse/Inquirer.net reports. The announcement came after five patients were confirmed to have H1N1 - the first cases in the region. "Hassan Khalaf, a spokesman for the Hamas health ministry, declined to give details but said the condition of three other people who on Sunday had been confirmed to have contracted A(H1N1) was improving," according to the news service (12/7).

With the reports that H1N1 has reached Gaza, the Associated Press/Jerusalem Post examines growing concern that there are not enough H1N1 vaccines to distribute to the health workers in the region (12/6).

Gaza's Health Ministry has reached out to the WHO for assistance to contain and treat the virus, according to VOA News. "Neighboring Israel has a blockade on Gaza, and Egypt restricts movement across its border with the Hamas-controlled territory. Health officials say that isolation likely kept the H1N1 virus from affecting the coastal territory sooner," the news service adds (12/6).

The WHO has confirmed the first case of H1N1 in the Southern Sudan region of Juba, the Sudan Tribune reports (12/5).

The WHO reported Friday that 207 countries and territories worldwide have reported cases of H1N1 and at least 8,768 people worldwide have died from the virus, RIA NOVOSTI reports (12/4).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows potential for universal flu vaccine with broad antibody response